Sharda Cropchem reported a robust Q3 FY26 performance with revenue increasing by 39% to INR 1,289 crores. Agrochemical segment grew by 48%, driven by strong volume growth and improved product mix. The company achieved its highest-ever PAT for any year. It anticipates continued growth momentum in Q4 FY26 and FY27, supported by product registrations and favorable industry dynamics. An interim dividend of INR 6 per share was declared.
Financial Performance
In Q3 FY26, Sharda Cropchem’s revenue reached INR 1,289 crores, a 39% increase compared to INR 929 crores in Q3 FY25. The Agrochemical business segment saw a 48% year-on-year growth, reaching INR 1,141 crores, while the non-agrochemical business decreased by 8.1% to INR 148 crores.
Gross margin stood at 34.9% in Q3 FY26, up from 32.7% in Q3 FY25. EBITDA increased by 59% to INR 245.5 crores, with an EBITDA margin of 19.1%. PAT stood at INR 145.1 crores, a significant increase from INR 31 crores in the previous year.
For 9M FY26, revenue was reported at INR 3,203 crores, a 29% increase year-on-year. The Agrochemical business grew by 34% to INR 2,790 crores. EBITDA for the 9-month period stood at INR 526.7 crores, with a margin of 16.4%. PAT for 9M FY26 reached INR 362 crores.
Key Highlights
The company’s total product registrations stood at 3,004 as of December 31, 2025, with 1,076 additional applications under approval. The company is net debt-free with cash and bank liquid investments of INR 826 crores as of December 31, 2025.
Segment Performance
Agrochemical volumes increased by approximately 15%, while non-agrochemical volumes grew by 14% year-on-year. Europe and Latin America have been significant contributors to volume growth.
Future Outlook
The company anticipates gross margins to remain stable for FY26 and expects revenue growth of 15% to 20% in FY27. Capex for FY27 is expected to be in the range of INR 450 crores to INR 500 crores.
Source: BSE
